China SHESAYS (CSAY.OB) Introduces CEREC AC; Anticipates Solid Presence in Cosmetic Dentistry Industry

QualityStocks would like to highlight China SHESAYS (OTCBB: CSAY). The company operates a chain of specialized medical cosmetology hospitals, clinics, and skincare centers in Sichuan province, China. They offer a full range of services including cosmetic surgery, cosmetic dermatology, cosmetic dentistry, and cosmetic Traditional Chinese Medicine ("TCM"). Headquartered in Chengdu, China, the company has become one of the fastest growing cosmetology businesses in China, and is one of the most renowned cosmetology hospital chains in Sichuan province.

In the company’s news yesterday,

China SHESAYS Medical Cosmetology announced that it has recently unveiled its CEREC AC porcelain teeth 3D restoration robot at its flagship hospital in Chengdu. The introduction establishes China SHESAYS as the first medical cosmetology company in China to apply this dental instrument to cosmetic dentistry procedures.

The CEREC AC robot is a dental restoration system primarily used for making porcelain prosthetic teeth, providing rapid imaging results by leveraging the CEREC Bluecam technology to capture highly detailed images of dental conditions by using a powerful blue light emitting diode.

The company said the robot is expected to change the current operating model for dental restoration. The robot has the capability to significantly shorten the time for making a porcelain tooth from one week to an hour, and the company expects the robot to help add approximately 100 customers for dental restoration within a year.

China SHESAYS invested approximately $181,000 for the CEREC AC robot. The company estimates the cost of restoring a porcelain tooth to be between $300 and $900; the average customer will restore between eight and 16 porcelain teeth – as such, the company estimates that the revenue per patient on average is approximately $6,000.

Yixiang Zhang, chairman and CEO of China SHESAYS, noted the robot’s benefits to patients and said the company expects these benefits to appeal to a broad clientele.

“Instead of waiting for a week for permanent prosthetic teeth while having to use uncomfortable replacement prosthetics during the interim period, customers are offered a significantly more convenient alternative. As customers can actually witness the prosthetic tooth preparation process while they are in our hospital, we believe this level of transparency and efficiency will attract a broad clientele. In the future, we are committed to continuously improving all aspects of our customer service experiences as we strongly believe this is our key differentiator from our competitors,” Zhang stated in the press release.

China SHESAYS also anticipates that the CEREC AC will strengthen the company’s position in the cosmetic dentistry industry.

“The introduction of the CEREC AC robot is also expected to significantly enhance our technological advantage in cosmetic dentistry, and further enhance the brand equity for our hospital. Our cooperation with Sirona, dubbed as the world’s largest manufacturer of dental equipment, represents a significant milestone in achieving our leadership in medical equipment applications in China,” Zhang stated.

About QualityStocks

QualityStocks, based in Scottsdale, Arizona, is a free service that collects data from hundreds of Small-Cap and Micro-Cap online Investment Newsletters into one Daily Newsletter Report. QualityStocks is dedicated to assisting emerging public companies with their investor communication efforts and connecting subscribers with companies that have huge potential to succeed in the short and long-term future.

To sign up for “The QualityStocks Daily Newsletter” please visit www.QualityStocks.net

Please see disclaimer on QualityStocks website: http://Disclaimer.QualityStocks.net

Forward-Looking Statement:

This release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. Risks and uncertainties applicable to the company and its business could cause the company's actual results to differ materially from those indicated in any forward-looking statements.